EP3585407A4 - Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof - Google Patents

Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof Download PDF

Info

Publication number
EP3585407A4
EP3585407A4 EP18757495.9A EP18757495A EP3585407A4 EP 3585407 A4 EP3585407 A4 EP 3585407A4 EP 18757495 A EP18757495 A EP 18757495A EP 3585407 A4 EP3585407 A4 EP 3585407A4
Authority
EP
European Patent Office
Prior art keywords
herbo
preparation
treatment
vascular diseases
cardio vascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18757495.9A
Other languages
German (de)
French (fr)
Other versions
EP3585407A2 (en
Inventor
Dr. M Vijayabhanu SHETTY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Muniyal Ayurvedic Research Centre
Original Assignee
Muniyal Ayurvedic Research Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muniyal Ayurvedic Research Centre filed Critical Muniyal Ayurvedic Research Centre
Publication of EP3585407A2 publication Critical patent/EP3585407A2/en
Publication of EP3585407A4 publication Critical patent/EP3585407A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP18757495.9A 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof Withdrawn EP3585407A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741006955 2017-02-27
PCT/IN2018/050102 WO2018154608A2 (en) 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof

Publications (2)

Publication Number Publication Date
EP3585407A2 EP3585407A2 (en) 2020-01-01
EP3585407A4 true EP3585407A4 (en) 2021-01-20

Family

ID=63254299

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18757495.9A Withdrawn EP3585407A4 (en) 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof

Country Status (9)

Country Link
EP (1) EP3585407A4 (en)
JP (1) JP2020512301A (en)
KR (1) KR20190132388A (en)
CN (1) CN110891585A (en)
AU (1) AU2018223381A1 (en)
BR (1) BR112019017594A2 (en)
CA (1) CA3054271A1 (en)
RU (1) RU2019130384A (en)
WO (1) WO2018154608A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100652A1 (en) * 2009-02-04 2010-09-10 Sharma, Anurag Ayurvedic formulation for treating coronary heart disease
US20120034326A1 (en) * 2010-08-09 2012-02-09 Srm University Novel herbal formulation advocated for the prevention and management of coronary heart disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583499B1 (en) * 2002-01-13 2009-07-22 Department Of Biotechnology A novel polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia
US8017147B2 (en) * 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
EP1974737A1 (en) * 2007-03-23 2008-10-01 Phyto Health Pharma B.V. Composition for the treatment of diabetes mellitus and metabolic syndrome
US8895075B2 (en) * 2007-09-20 2014-11-25 Atul M. Desai Herbomineral formulation for treating sickle cell disease
US8962576B2 (en) * 2012-03-30 2015-02-24 Natreon, Inc. Compositions and method for improving endothelial function and cardiovascular health
US10639341B2 (en) * 2017-04-24 2020-05-05 Muniyal Ayurvedic Research Centre Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100652A1 (en) * 2009-02-04 2010-09-10 Sharma, Anurag Ayurvedic formulation for treating coronary heart disease
US20120034326A1 (en) * 2010-08-09 2012-02-09 Srm University Novel herbal formulation advocated for the prevention and management of coronary heart disease

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 17 January 2009 (2009-01-17), ANONYMOUS: "Ayurvedic Herb Tablets", XP055580389, Database accession no. 1033665 *
EUGENE WILSON ET AL: "Review on shilajit used in traditional Indian medicine", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 136, no. 1, 12 April 2011 (2011-04-12), pages 1 - 9, XP028374544, ISSN: 0378-8741, [retrieved on 20110420], DOI: 10.1016/J.JEP.2011.04.033 *
LOKHANDE PD ET AL: "Natural remedies for heart diseases", INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE, RESOURCES, NEW DELHI, NEW DELHI - INDIA, vol. 5, no. 3, 1 July 2006 (2006-07-01), pages 420 - 427, XP018021446, ISSN: 0972-5938 *
MISBAHUDDIN AZHAR ET AL: "Pharmacologically Active Cardioprotective Plants at a Glance", HAMDARD MEDICUS, vol. 58, no. 1, 1 January 2015 (2015-01-01), pages 51 - 83, XP055467033 *
RASTOGI SUBHA ET AL: "Traditional herbs: a remedy for cardiovascular disorders", PHYTOMEDICINE, ELSEVIER, AMSTERDAM, NL, vol. 23, no. 11, 10 November 2015 (2015-11-10), pages 1082 - 1089, XP029687140, ISSN: 0944-7113, DOI: 10.1016/J.PHYMED.2015.10.012 *
S RAMADOSS ET AL: "Efficacy of Cardioprotective Effects in Ethanolic Extract of Sida Rhombifolia Linn. On Isoproterenol-Induced Myocardial Infarction in Albino Rats", RESEARCH JOURNAL OF PHARMACEUTICAL, BIOLOGICAL AND CHEMICAL SCIENCES, 1 April 2012 (2012-04-01), XP055759525, Retrieved from the Internet <URL:https://www.rjpbcs.com/pdf/2012_3(2)/ 57!.pdf> [retrieved on 20201214] *

Also Published As

Publication number Publication date
RU2019130384A (en) 2021-03-29
CA3054271A1 (en) 2018-08-30
WO2018154608A2 (en) 2018-08-30
JP2020512301A (en) 2020-04-23
BR112019017594A2 (en) 2020-03-24
KR20190132388A (en) 2019-11-27
CN110891585A (en) 2020-03-17
AU2018223381A1 (en) 2019-10-17
WO2018154608A3 (en) 2018-11-01
EP3585407A2 (en) 2020-01-01

Similar Documents

Publication Publication Date Title
EP3464381A4 (en) Compounds and methods for the treatment of trop2 positive diseases
EP3681479A4 (en) Method of administration and treatment
EP3716767A4 (en) Methods and compositions for the treatment of rare diseases
PT3377637T (en) Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3694832A4 (en) Extended release pharmaceutical formulation and methods of treatment
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
EP3538119A4 (en) Compositions and methods for treating skin diseases and maintaining healthy skin
EP3621593A4 (en) Pharmaceutical compositions and methods of treating cardiovascular diseases
EP3675871A4 (en) Compositions and methods for the treatment of fibrotic diseases
EP3600286A4 (en) Compounds and methods for the treatment of parasitic diseases
EP3484526A4 (en) Compositions and methods for treatment of cardiac diseases
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3678701A4 (en) Therapeutic protein compositions and methods of making and using the same
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
EP3713583A4 (en) Methods and compositions for treatment of skin
EP3713553A4 (en) Compositions and methods for treatment of eye diseases
EP3740592A4 (en) Methods and compositions for the treatment of vascular disease
EP3849591A4 (en) Methods and compositions for treating skin diseases
EP3459524A4 (en) Human body cleaning agent and preparation method therefor
EP3730509A4 (en) Compound for treating metabolic diseases and preparation method and use thereof
EP3654964A4 (en) Composition and methods for the treatment of myopia
IL272495A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
EP3766503A4 (en) Application of microrna-210 inhibitor in the preparation of drugs for treating inflammatory skin diseases
EP3576761A4 (en) Herbo-mineral formulation for the treatment of cancer and method of preparation thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190924

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201222

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/47 20060101ALI20201216BHEP

Ipc: A61K 36/24 20060101AFI20201216BHEP

Ipc: A61K 36/258 20060101ALI20201216BHEP

Ipc: A61K 36/37 20060101ALI20201216BHEP

Ipc: A61K 31/352 20060101ALI20201216BHEP

Ipc: A61K 36/185 20060101ALI20201216BHEP

Ipc: A61K 36/81 20060101ALI20201216BHEP

Ipc: A61K 36/328 20060101ALI20201216BHEP

Ipc: A61K 36/59 20060101ALI20201216BHEP

Ipc: A61P 9/00 20060101ALI20201216BHEP

Ipc: A61K 31/05 20060101ALI20201216BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210730